-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-03-11
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1288.5Change
-29.00 (-2.20)%Market Cap
N/AVolume
195.00Analyst Target
N/A
N/A
Verdict
Values as of: 2025-03-11
COMMON STOCK | Other |
Last Closing
USD 1288.5Change
-29.00 (-2.20)%Market Cap
N/AVolume
195.00Analyst Target
N/AN/A
Verdict
There is no Profile data available for 3020-OL.HK.
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
N/A |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
+0.03 (+4.92%) |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0177-OL:HK | JIANGSU EXPRESS |
+0.16 (+1.82%) |
N/A |
0243-OL:HK | QPL INT'L |
-0.02 (-9.60%) |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
+0.05 (+2.73%) |
N/A |
0187-OL:HK | JINGCHENG MAC |
-0.78 (-15.48%) |
N/A |
0272-OL:HK | SHUI ON LAND |
N/A |
N/A |
0239-OL:HK | PAK FAH YEOW |
+0.03 (+1.40%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
IHF | iShares U.S. Healthcare P.. | 11.24 % | 0.43 % |
-0.08 (-0.49%) |
N/A |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
BGU-U:CA | Bristol Gate Concentrated.. | 5.48 % | 0.00 % |
-0.27 (-0.49%) |
CAD 0.11B |
FHI-B:CA | CI Health Care Giants Cov.. | 5.10 % | 0.00 % |
N/A |
CAD 0.05B |
MID | American Century Mid Cap .. | 4.56 % | 0.00 % |
+0.03 (+-0.49%) |
USD 0.08B |
LCG | Sterling Capital Focus Eq.. | 4.21 % | 0.00 % |
-0.16 (-0.49%) |
USD 0.03B |
IAI | iShares U.S. Broker-Deale.. | 4.18 % | 0.42 % |
+0.01 (+-0.49%) |
N/A |
UTRN | Vesper U.S. Large Cap Sho.. | 4.10 % | 0.00 % |
-0.27 (-0.49%) |
USD 0.01B |
CBSE | Elevation Series Trust | 3.05 % | 0.00 % |
+0.70 (+-0.49%) |
USD 0.02B |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
CBLS | Elevation Series Trust | 2.77 % | 0.00 % |
+0.43 (+-0.49%) |
USD 0.04B |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
+0.18 (+-0.49%) |
USD 0.04B |
JKH | iShares Morningstar Mid-C.. | 0.00 % | 0.30 % |
N/A |
N/A |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.00 % | 0.40 % |
-0.43 (-0.49%) |
N/A |
WBIF | WBI BullBear Value 3000 E.. | 0.00 % | 1.05 % |
-0.24 (-0.49%) |
N/A |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
FSWD:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
-11.63 (-0.49%) |
N/A |
IFSW:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
-0.13 (-0.49%) |
N/A |
IBCZ:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
-0.09 (-0.49%) |
N/A |
IS07:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
-0.23 (-0.49%) |
N/A |
IS07:XETRA | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
-0.06 (-0.49%) |
N/A |
CBUF:XETRA | iShares MSCI World Health.. | 0.00 % | 0.00 % |
-0.19 (-0.49%) |
N/A |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
-0.35 (-0.49%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -5.19% | 32% | F | 34% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -5.19% | 32% | F | 34% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 9.52% | 60% | D- | 62% | D | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 9.52% | 57% | F | 60% | D- | ||
Trailing 5 Years | |||||||
Capital Gain | 128.86% | 79% | B- | 92% | A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 128.86% | 79% | B- | 90% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 17.29% | 78% | C+ | 76% | C+ | ||
Dividend Return | 17.29% | 77% | C+ | 74% | C | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 20.14% | 75% | C | 74% | C | ||
Risk Adjusted Return | 85.88% | 98% | N/A | 97% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
There is nothing we particularly dislike